Galecto Reports Operating and Financial Results for the Year Ended December 31, 2022
Galecto, Inc. (GLTO)
Company Research
Source: GlobeNewswire
BOSTON, March 09, 2023 (GLOBE NEWSWIRE) -- Galecto, Inc. (NASDAQ: GLTO), a clinical-stage biotechnology company and world leader in galectin biology focused on the development of novel treatments for fibrosis and cancer, today announced its operating and financial results for the quarter and year ended December 31, 2022. “2022 was an exciting year for us as we continued to progress our pipeline of small-molecule inhibitors of galectin-3 and LOXL2 and we now have three novel compounds in Phase 2 supported by positive clinical data. We are highly encouraged by the clinical results reported in 2022, including with GB1211 in decompensated liver cirrhosis and with GB2064 in myelofibrosis, which provide further evidence of the key roles of galectin-3 and LOXL2 in regulating fibrosis,” said Hans Schambye, CEO of Galecto. “We are looking forward to building on this momentum with further significant milestones in 2023, including top-line Phase 2b results on GB0139 in idiopathic pulmonary
Show less
Read more
Impact Snapshot
Event Time:
GLTO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GLTO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GLTO alerts
High impacting Galecto, Inc. news events
Weekly update
A roundup of the hottest topics
GLTO
Earnings
- 7/31/23 - Beat
GLTO
Sec Filings
- 4/16/24 - Form PRE
- 3/26/24 - Form 8-K
- 3/8/24 - Form S-8
- GLTO's page on the SEC website